APPLICATIONS PUBLISHED 23 MARCH 2005

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

Abuse-resistant opioid solid dosage form
Endo Pharmaceuticals 151564*

Short duration depot formulations
Alza Corp 1515697*

Liposomes containing biologically active compounds
Piedmont Pharmaceuticals 1515698*

Process for loading and thermodynamically activating drugs on polymers by means of supercritical fluids
Eurand Pharmaceuticals 1515699*

Controlled alignment of catalytically grown nanostructures in large-scale synthesis process
UT-Battelle 1515700*

Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
Themis Laboratories 1515701*

Abuse protected administration form
Gruenenthal 1515702*

Pharmaceutical compsns with improved dissolution
Transform Pharmaceuticals 1515703*

Microcapsules for the delayed, controlled release of perindopril
Les Laboratoires Servier 1515704*

Fluorosiloxane matrix controlled diffusion drug delivery system
Bausch & Lomb 1515705*

A platform for transdermal formulations
Holden Development 1515706*

Method of treating atherosclerosis and other inflammatory diseases
Imclone Systems; Vlaams Interuniversitair Instituut voor Biotechnologie; Desire Collen Research Foundation 1515707*

Combinations of PDE-V inhibitors and NK1 antagonists for the treatment of depression
Pfizer Products 1515708*

Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder
Warner-Lambert 1515709*